The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics

scientific article published on 26 October 2018

The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11886-018-1075-7
P698PubMed publication ID30367282

P50authorW. Gregory HundleyQ96107821
P2093author name stringAmitabh Parashar
P2860cites workCardiac dysfunction in the trastuzumab clinical trials experienceQ28204298
Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imagingQ30450980
Cardiovascular magnetic resonance physics for clinicians: part I.Q30497816
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trQ33973013
Identification of the molecular basis of doxorubicin-induced cardiotoxicityQ34308627
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effectsQ34580448
Interruption and non-adherence to long-term adjuvant hormone therapy is associated with adverse survival outcome of breast cancer women--an Asian population-based studyQ35105896
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclinesQ36395125
Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapyQ36625503
Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.Q36944395
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular diseaseQ37100862
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.Q38452328
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.Q38522479
Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological ValidationQ40096735
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast CancerQ40219720
Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer SurvivorsQ40630785
Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapyQ41229022
Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricleQ41786860
Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclinesQ44780572
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submiQ45716509
Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicityQ45893753
Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosisQ46615830
Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicityQ46947055
Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.Q48771344
Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.Q51292585
Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) TrialQ51293272
Real-time imaging of two-dimensional cardiac strain using a harmonic phase magnetic resonance imaging (HARP-MRI) pulse sequence.Q51666927
Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis.Q52885859
Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.Q52886112
Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error.Q53054706
Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosisQ56986003
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular ImagingQ57603968
Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathiesQ58046350
CMR-Based Differentiation of AL and ATTR Cardiac AmyloidosisQ58853065
Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort StudyQ61868132
Estimation of human myocardial mass with MR imagingQ70062263
Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot studyQ73933979
Doxorubicin-induced cardiomyopathyQ77323607
Long-term risk of cardiovascular disease in 10-year survivors of breast cancerQ79887212
Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditisQ83273756
The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treatedQ84203423
Left Ventricular Mass Change After Anthracycline ChemotherapyQ89506732
When Left Ventricular Extracellular Volume Fraction Changes After Anthracyclines: Is it Due to a Change in the Numerator, Denominator, or Both?Q90857291
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)142
P577publication date2018-10-26
P1433published inCurrent cardiology reportsQ26842345
P1476titleThe Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics
P478volume20

Search more.